Cite
HARVARD Citation
Moehrle, J. et al. (n.d.). First‐in‐man safety and pharmacokinetics of synthetic ozonide OZ439 demonstrates an improved exposure profile relative to other peroxide antimalarials. British journal of clinical pharmacology. pp. 535-548. [Online].